Connect with us

Author: mc_admin

WHAT IS TUBERCULOSIS? Tuberculosis or “TB” is a treatable contagious disease that usually infects the lungs. It is caused by Mycobacterium tuberculosis bacilli and it can also be seen in the brain, skin, and other body organs. It is prevalent in densely populated countries such as China, India, Indonesia, and the Philippines. WHAT’S GOING ON … Continue reading World Tuberculosis Day: A Call To Action

SINGAPORE – February 15, 2017 Singapore-based HealthTech startup mClinica has raised $6.3 million in Series A funding to expand its operations globally. The company has developed mobile technology to unite pharmacies on a common platform, provide access to new sources of data, and allow for the deployment of data-driven programs that improve patient affordability and health … Continue reading mClinica Raises $6.3 Million to Transform Global Health Data

Despite mounting concern about the overuse and misuse of antibiotics, many physicians continue to make prescribing errors that amplify the problem. Many pharma companies have expressed support for solutions, but will they follow through on their promises? Antibiotic prescribing errors take many forms. The most common error is overuse. Around the world, physicians routinely prescribe … Continue reading Why Pharma MNCs Should Pursue Antibiotic Stewardship

As concerns mount about Indonesia’s growing diabetes epidemic, many organizations are working to increase awareness and improve treatment of the disease. Yet good data on the burden of diabetes and patient treatment pathways remains limited. mClinica has several datasets that can help. One such dataset is based on a longitudinal sample of prescription information that … Continue reading Diabetes in Indonesia: What Medicines do Physicians Prefer?

Above: Jake Josol, mClinica’s Director of Software Services, with Mme Béatrice Garrette, Director General of the Pierre Fabre Foundation. On July 4, mClinica had the honor of receiving the Pierre Fabre Foundation Prize for e-health innovation. The prize was received at a conference hosted by the Pierre Fabre Foundation, a French organization dedicated to improving healthcare in … Continue reading mClinica Wins Pierre Fabre Foundation Prize for E-health Innovation

With one of the largest diabetic patient populations in Asia and millions of undiagnosed cases, Indonesia poses both opportunities and challenges for healthcare organizations focused on diabetes. For those seeking insight on this topic, mClinica is pleased to present its first SnapShot report on Jakarta, Indonesia’s most important healthcare hub. Using mClinica’s proprietary prescription datasets, the … Continue reading REPORT: Diabetes in Jakarta–Rx Market SnapShot 2016

Antibiotics are one of the most widely prescribed types of medicines in Indonesia today, but data on their usage is not widely available. For healthcare organizations seeking insight on the current state of Indonesia’s antibiotics market, mClinica is pleased to present its first SnapShot report on the OOP market in Jakarta, Indonesia’s most important healthcare … Continue reading REPORT: Antibiotics in Jakarta–Rx Market SnapShot 2016

Vietnam has one of the fastest-growing diabetic patient populations in Asia. As incidence soars, pharmaceutical companies and healthcare providers are racing to keep up with demand for diabetes treatments. Epidemiological and regulatory shifts further complicate the picture, making careful monitoring of market dynamics a necessity. For healthcare organizations seeking insight on the current state of … Continue reading REPORT: Diabetes in Ho Chi Minh City–Rx Market SnapShot 2016

As global health organizations ramp up efforts to fight the spread of drug-resistant microbes, many recognize a growing need to collect robust data on risk factors for antimicrobial resistance (AMR). At mClinica, we have data collection and patient engagement platforms that can help. We manage these platforms in Asia’s emerging markets. In the Philippines, Indonesia, … Continue reading How mClinica Can Support AMR Surveillance in Southeast Asia

Antibiotics are one of the most widely prescribed types of medicines in Vietnam today, but market dynamics for these critical medicines are not widely understood. For healthcare organizations seeking insight on the current state of Vietnam’s antibiotics market, mClinica is pleased to present its first SnapShot report on the OOP market in Ho Chi Minh … Continue reading REPORT: Antibiotics in Ho Chi Minh City—Rx Market SnapShot 2016